Document:

EX-10.2

 Exhibit 10.2 

SECOND AMENDMENT TO ASSET PURCHASE AGREEMENT 

This Second Amendment to Asset Purchase Agreement (the “Amendment”) is made and entered into as of this 28th day of August,
2022, by and Asurion, LLC, a Delaware limited liability company (“Buyer”), and Enjoy Technology, Inc., a Delaware corporation (“Enjoy”), Enjoy Technology Operating Corp., a Delaware corporation (“Enjoy
Operating”) and Enjoy Technology LLC, a Delaware limited liability company (“Enjoy LLC” and, together with Enjoy and Enjoy Operating, each a “Seller” and, collectively, “Sellers”). Buyer
and Sellers are collectively referred to herein as the “Parties” and individually as a “Party”. Capitalized but undefined terms in this Amendment shall have the meanings given them in the Asset Purchase Agreement
(the “Purchase Agreement”), dated as of July 25, 2022 (and as previously amended by that certain First Amendment to the Purchase Agreement, dated as of August 1, 2022), by and among the Parties. 

RECITALS: 
  

	A.	 Section 12.6 of the Purchase Agreement provides that the Purchase Agreement
may not be amended except by a written agreement signed by each of the Parties. 

  

	B.	 The Parties desire to enter into this Amendment and amend the Purchase Agreement as set forth herein.

 AGREEMENT 

For valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereby agree as follows: 

1. Amendment to Purchase Agreement. The definition of “Outside Date” of Section 12.16(mmmm) of the Purchase Agreement is hereby
amended and restated in full as follows: 
 (mmmm) “Outside Date” means August 31, 2022. 

2. Full Force and Effect. Except as modified or amended hereby, the provisions, conditions and terms of the Purchase Agreement shall remain
unchanged and in full force and effect. In the case of any inconsistency between the provisions of the Purchase Agreement and this Amendment, the provisions of this Amendment shall govern and control. 

3. Counterparts. This Amendment may be executed in one or more counterparts, each of which will be deemed to be an original copy of this
Amendment and all of which, when taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Amendment and of signature pages by facsimile, or by .pdf or similar imaging transmission, will constitute
effective execution and delivery of this Amendment as to the Parties and may be used in lieu of the original Amendment for all purposes. Signatures of the Parties transmitted by facsimile, or by .pdf or similar imaging transmission, will be deemed
to be their original signatures for any purpose whatsoever. 
 [remainder of page intentionally left blank] 

  
 1 

 IN WITNESS WHEREOF, the Parties have executed this Amendment as of the date first written
above. 
  

			
	BUYER:
	
	ASURION, LLC
		
	By:	 	 /s/ Roger Anthony Detter

	Name:	 	Roger Anthony Detter
	Title:	 	Chief Executive Officer

 [Signature Page to Second Amendment to Asset Purchase Agreement] 

 
			
	SELLERS:
	
	ENJOY TECHNOLOGY, INC.
		
	By:	 	 /s/ Ron Johnson

	Name:	 	Ron Johnson
	Title:	 	Chief Executive Officer
	
	ENJOY TECHNOLOGY OPERATING CORP.
		
	By:	 	 /s/ Ron Johnson

	Name:	 	Ron Johnson
	Title:	 	Chief Executive Officer
	
	ENJOY TECHNOLOGY LLC
		
	By:	 	 /s/ Ron Johnson

	Name:	 	Ron Johnson
	Title:	 	Chief Executive Officer

 [Signature Page to Second Amendment to Asset Purchase Agreement]Exhibit 10.1

 

 

August 29, 2022

 

Mr. Andrew M. Snyder

Cambridge Information Group

888 7th Ave., 17th Floor

New York, NY 10019

 

	Re:	Director Nomination Agreement dated as of December 1, 2021 between Clarivate Plc (the “Company”) and Andrew M. Snyder

 

Dear Andy:

 

In connection with your election as Chairman of the Board of the Company,
with effect as of the conclusion of the meeting of the Board scheduled for October 20, 2022, you offered to terminate and rescind the
above-referenced Director Nomination Agreement, and the Board accepted your offer. This letter memorializes the termination and rescission
of such Director Nomination Agreement in its entirety upon the effectiveness of your election as Chairman of the Board.

 

If the foregoing correctly reflects the agreement and understanding
between you and the Company, kindly execute the enclosed copy hereof in the space indicated and return a hard or electronic copy hereof
to the undersigned, whereupon this letter shall constitute a binding agreement between you and the Company as of the date first above
written.

 

Very truly yours,

 

CLARIVATE Plc

 

	By:	/s/ Jaspal Chahal	 
	 	Jaspal Chahal	 
	 	General Counsel	 

 

 

ACCEPTED AND AGREED:

 

	/s/ Andrew M. Snyder	 
	ANDREW M. SNYDERExhibit 10.2

 

 

 

August 31, 2022

 

Jerre Stead

[ADDRESS REDACTED]

 

Dear Jerre,

 

Congratulations on your retirement from Clarivate!
As you transition from your role as Chair and CEO, to Non-Executive Chair and then to Chair Emeritus, this letter agreement sets out below
the details of your retirement and separation from Clarivate.

 

This agreement, Attachments A and B hereto (collectively,
the “Agreement”) outlines the terms between the Clarivate group of companies (the “Company”) and you (the Company
and you are collectively referred to as the "Parties") regarding your retirement and transition from the Company.

 

The Parties agree as follows:

 

		1.	CEO: This Agreement confirms discussions concerning your retirement and transition
from employment effective September 1, 2022 (the “Employment Transition Date”). In connection with entering into this Agreement,
you acknowledge and agree that, effective from the Employment Transition Date, you will automatically retire from all your director and
officer positions of the Company, including your position as Chief Executive Officer of the Company, except as expressly set forth below.

 

		2.	Non-Executive Chair: Following the Employment Transition Date, you shall serve as the Non-Executive
Chair of the Company’s board of directors (the “Board”).

 

		3.	Chair Emeritus: Effective October 21, 2022 (the “Emeritus Transition Date”),
you will automatically retire from your position, as the Non-Executive Chair of the Board and shall transition to serving as the Chair
Emeritus of the Board, with the terms and conditions of service set forth in this Agreement (“Chair Emeritus”). You will continue
to serve as Chair Emeritus through the date of the Company’s 2025 annual shareholders meeting, currently anticipated to occur in
May 2025.

 

As Chair Emeritus, you shall
be subject to the following terms and conditions:

 

		A.	You shall make yourself available for consulting and advisory
services, which shall be provided at such times as may be reasonably requested from time to time by the Board or the Chief Executive
Officer, including attendance at any meeting of the Board or a committee thereof.
	 	 	 

		B.	If you attend any meetings of the Board, your presence or absence
at any such meeting shall not be taken into consideration for quorum purposes. You may not vote on any matter presented to the Board,
whether at any meeting of the Board or in the form of a written consent.
	 	 	 

		C.	You shall not be a member of the Board and your position shall not be subject to the election by the Company’s
shareholders. As Chair Emeritus, you shall not be subject to the fiduciary duties imposed on members of the Board, whether
by applicable law or by the Company’s Articles of Association.

 

    1

     

    

 

		4.	Compensation: 

 

 

 

		A.	Until the Employment Transition Date, you will continue to be paid your salary and other benefits through
the Company’s payroll. The Company will also reimburse you for any authorized business expenses incurred through your actual last
day worked.

 

		B.	Subject to your execution of this Agreement, you shall be eligible to receive a bonus under the Company’s
Annual Incentive Plan (“AIP”), calculated on the same basis and performance results as the Company’s other named executive
officers and pro-rated based on your service through the Employment Transition Date. Such bonus shall be paid at the same time as bonuses
are generally paid under the AIP and in no event later than March 15, 2023.

 

		C.	Your participation in employee benefits including shall terminate on August 31, 2022. On the Employment
Transition Date, you will not be entitled to receive any employee benefits, except for group health coverage continuation in accordance
with COBRA and 401(k) benefits, if any.

 

		D.	Except as set out in Paragraph 1.E below, you shall not be eligible to receive, and you expressly waive
any right you may otherwise have to, any compensation with respect to your service as the Non-Executive Chair of the Board or your service
as Chair Emeritus, whether under any director compensation policy adopted by the Company or otherwise.

 

		E.	Consistent with the terms of your existing award agreements, all unvested RSUs and PSUs you hold shall
remain outstanding and eligible to vest in accordance with their terms, subject to your continued service with the Company through the
applicable vesting date (including, for the avoidance of doubt, your service as Chair Emeritus) and, in the case of any PSUs, subject
to the achievements of the applicable performance metrics. In addition, consistent with the terms of your existing award agreements, all
unvested RSUs and PSUs you hold will vest immediately in the event of your death or disability and any outstanding, vested stock options
you hold shall remain outstanding and exercisable through the dates specified in such agreements.

 

		5.	Miscellaneous: 

 

 

		A.	Entire Agreement: This Agreement and each of your equity award agreements represents the entire
agreement of the Parties with respect to the subject matter hereof. All prior understandings relating to the subject matter of this Agreement,
whether oral or written, are hereby superseded by this Agreement other than any documents expressly referenced in this Agreement or incorporated
herein by reference. For the avoidance of doubt, the terms and conditions of any confidentiality obligations between you and the Company
under the equity agreements shall continue in force and effect following the date of this Agreement.

 

		B.	Cooperation: You hereby agree to reasonably cooperate with the Company after your retirement and
separation from the Company, in connection with any existing or potential claim, investigation, administrative proceeding, lawsuit or
other legal or business matter that arose during, or in connection with your employment with the Company. The Company shall reimburse
you for your reasonable out-of-pocket expenses incurred in connection therewith.

 

    2

     

    

 

		C.	Insurance: This Agreement does not affect or limit your rights, or benefits under any insurance
policies maintained by the Company including, but not limited to, D&O or other similar insurance policies, where you may be entitled
to indemnification, including cost of defense, in any lawsuit or claim involving acts or omissions by you in the course and scope of your
employment with the Company. The Company will continue to maintain appropriate insurance policies or indemnification in place covering
the period of your service to the Company. The Company will continue to provide you with indemnification and advancement of expenses pursuant
to any written indemnification agreement with the Company to which you are a party, the Memorandum and Articles of Association and other
organizational documents of the Company and by law .

 

		D.	Release: Attachment A contains a general release by you in favor of the Company. In addition, on
behalf of the Company and its subsidiaries, branches, divisions, and affiliates, the Company hereby irrevocably and unconditionally releases
and discharges you from any and all causes of action, suits, debts, claims, liabilities, demands, costs, expenses, attorneys’ fees,
damages, indemnities and obligations of any kind or nature, in law, equity or otherwise, known and unknown, suspected and unsuspected,
disclosed and undisclosed, foreseeable and unforeseeable, which have existed or may have existed, or which do exist, at any time prior
to and including the date on which the Company signs this Agreement, other than any claims that cannot lawfully be waived and provided
that this release shall not extend to any matter in respect of any actual fraud or willful default which may attach to you.

 

		E.	Restrictive Covenants: Notwithstanding anything in any other agreement between you and the Company
to the contrary relating to the restrictive covenants, you undertake to comply with the restrictive covenant obligations contained in
Attachment B.

 

		F.	Non-Disparagement: The Parties agree that,
before and at any time following the expiration of the Chairman Emeritus position, neither party will engage in any disparagement and
will refrain from making any false, negative or critical statement, implied or expressed, concerning the Company or you. The Parties further
agree to do nothing that would damage your or the Company’s reputation.

 

		G.	Whistleblower Reporting: Nothing in this Agreement nor otherwise is intended to prohibit you from
disclosing this Agreement to, or from cooperating with or reporting violations to, the SEC or any other such governmental authority or
self-regulatory organization, and you may do so without notifying the Company. The Company may not retaliate against you for any of these
activities, and nothing in this Agreement or otherwise would require you to waive any monetary award or other payment that you might become
entitled to from the SEC or any other governmental authority.

 

		H.	Governing Law: This Agreement shall be governed by and construed in accordance with the laws of
the State of Arizona, except where preempted by federal law. Should any provision of this Agreement be declared illegal or unenforceable
by any court of competent jurisdiction and cannot be modified to be enforceable, such provision shall immediately become null and void,
leaving the remainder of the Agreement in full force and effect. Should the general release in Attachment A be declared unlawful or unenforceable
by a court of competent jurisdiction, you agree to sign a new general release which is in a form acceptable to the Company for no additional
consideration.

 

		6.	Execution: Subject to your later revocation as set forth below, you have 21 days following
the Employment Transition Date to consider and to execute this Agreement. If you choose not to execute this Agreement during that time
period you will forfeit the right to receive the benefits provided in this Agreement and this Agreement will be deemed to be automatically
withdrawn and of no legal effect. You understand that you may revoke your acceptance of this Agreement after signing it by delivering
a written notice of your decision to revoke within 7 calendar days after the acceptance date. You understand that your right to receive
the benefits outlined in this Agreement shall be forfeited if you revoke your signature within the revocation period. You also acknowledge
that but for this Agreement, you would not be entitled to the benefits set forth in Paragraph 4.B or the benefits provided by the opportunity
to continue to serve as Chairman Emeritus.

 

    3

     

    

 

Let me take this opportunity to express on behalf
of the board, leadership team and all of the colleagues thank you for your leadership and guidance. It has been a pleasure to work with
you to position Clarivate for a successful future.

 

Sincerely,

 

	On
    behalf of Clarivate	 
	 	 
	/s/
    Julie Wilson	 
	 	 
	Julie
    Wilson	 
	Chief
    People Officer	 
	 	 
	Accepted
    and Agreed by:	 
	 	 
	/s/
    Jerre Stead	 
	Jerre
    Stead	 
	 	 
	Date	August
    31, 2022	 

 

    4

     

    

 

 

 

ATTACHMENT A

 

RELEASE

 

Pursuant to the Agreement to which this Release
is attached, you acknowledge and agree as follows:

 

		1.	General Release: In consideration for the payments and benefits described herein, on behalf
of yourself, your predecessors, heirs, executors, administrators, successors and assigns, you hereby irrevocably and unconditionally release
and discharge the Company and its and their past, present, and future parents, subsidiaries, branches, divisions, and affiliates, and
its and their past, present, and future shareholders, employees, officers, directors, agents, representative, fiduciaries and attorneys,
individually and in their official capacities (collectively, the “Released Parties”), from any and all causes of action, suits,
debts, claims, liabilities, demands, costs, expenses, attorneys’ fees, damages, indemnities and obligations of any kind or nature,
in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed, foreseeable and unforeseeable, which
have existed or may have existed, or which do exist, at any time prior to and including the date on which you sign this Agreement, other
than any claims that cannot lawfully be waived. This release includes, but is not limited to, any and all claims for employment discrimination
including, but not limited to, any and all claims under federal, state or local fair employment laws or practices or other employee relations
statutes and amendments (including without limitation the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964, the Civil
Rights Act of 1991, the Lilly Ledbetter Fair Pay Act of 2009, the Americans with Disabilities Act, the Age Discrimination in Employment
Act, the Family and Medical Leave Act, the Occupational Safety and Health Act, and the Sarbanes-Oxley Act of 2002), Executive Order 11246;
42 U.S.C. §§ 1981, 1985, 1988, any and all other claims arising under any federal, state, or local constitutional law, statutory
law, common law, regulations, ordinances, or equity, contract, or other source of law, including any and all claims or rights under federal,
state or local laws, regulations or ordinances relating to the payment of wages, bonuses, incentives and other compensation to employees;
any and all claims arising under the laws of the State of Arizona; any and all claims arising under the Worker Adjustment and Retraining
Notification Act (WARN), and any applicable state laws that provide for benefits similar to WARN; any and all claims pursuant to any other
federal, state or local statutes, regulations, ordinances or executive orders; any and all claims based on any rule, common law or public
policy; any and all claims based in contract, whether oral or written, express or implied; any claims based in tort, or any other obligation.
You confirm that you have not filed any claim in a civil action or complaint in an administrative action against the Company, that no
claims or complaints or other proceedings are pending in any court or other forum relating directly or indirectly to your employment with
the Company and/or separation from employment, and that you have not raised a claim of discrimination or harassment with the Company.
You affirm that you have been provided and/or have not been denied any leave requested under the Family and Medical Leave Act or applicable
state leave laws. You further affirm that you have been paid and received all compensation, wages, bonuses, commissions and benefits due
to you as of the date you sign this Agreement. You confirm and acknowledge that this Agreement reflects any and all separation and/or
severance payments to which you are entitled under any applicable plan, agreement or practice.

 

		2.	You understand that by signing this Agreement you are providing a complete waiver of all claims that may
have arisen, whether known or unknown, up until the time that this Agreement is executed by you, other than any claims that cannot lawfully
be waived. You are not waiving any rights to enforce the terms of the Agreement, including your rights to indemnification, as an officer
and/or director of the Company pursuant to
the Company’s Memorandum and Articles of Association. It is understood that this Agreement does not constitute an admission of liabilities
on the part of the Released Parties, by whom any liability is expressly denied, but is instead made to terminate any controversy or potential
controversy with respect to your employment or the cessation of your employment with the Company.

 

    5

     

    

 

		3.	Since the execution of this Agreement releases the Company and the Released Parties from all claims you
may have, the Company advises you to take time to consider this Agreement and to consult with an attorney of your choice prior to signing
it. Please indicate your understanding, acceptance and approval of this Agreement by signing your name and dating your signature where
indicated below.

 

		4.	BY SIGNING BELOW, YOU ACKNOWLEDGE THAT YOU HAVE READ AND UNDERSTOOD THE TERMS AND CONDITIONS OF THIS
AGREEMENT, THAT YOU HAVE BEEN ADVISED TO CONSULT WITH COUNSEL OF YOUR CHOICE AND THAT YOU KNOWINGLY AND VOLUNTARILY ENTER INTO THIS AGREEMENT
INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS YOU HAVE OR MIGHT HAVE AGAINST THE COMPANY AND THE RELEASED PARTIES UP TO THE DATE YOU
SIGNED THIS AGREEMENT.

 

I acknowledge and agree that
I must return an executed copy of this Release to Julie Wilson.

  

	Accepted
    and Agreed by:	 
	 	 
	/s/
    Jerre Stead	 
	Jerre
    Stead	 
	 	 
	Date 	August 31, 2022	 

 

    6

     

    

 

ATTACHMENT B

 

RESTRICTIVE COVENANTS

 

		A.	Non-Competition. You agree that during the remainder of the term of your service with the Company,
but in no event longer than the period ending May 31, 2025 (the “Relevant Period”), you will not directly or indirectly:
	 	 	 

		a.	Provide to a Competitive Enterprise the same or similar services that you performed during your employment
with the Company. For purposes of this Agreement, “Competitive Enterprise” shall mean any entity that engages in any business
of the Company which you were actively involved with at any time during the twelve (12) months immediately before the Employment Transition
Date; or
	 	 	 

		b.	Own more than 5% of a Competitive Enterprise the securities of which are listed on national securities
exchange or own more than 10% of a Competitive Enterprise whose securities are not listed on a national securities exchange at the time
of the investment.

 

You acknowledge that the Company is
involved in a global business ad it is reasonable and necessary to protect the Company’s legitimate business interests for the provisions
of this  Paragraph A to apply to the United States and in any other country where you provided services for and/or on behalf of the
Company during the twelve (12) months prior to the Employment Transition Date.

 

		B.	Non-Solicitation of Customers.  You agree that during the Relevant Period, you will not directly
or indirectly solicit or call upon with any current, former or prospective customer of the Company for the purpose of providing or obtaining
any product or service reasonably deemed competitive with any product or service then offered by the Company. This restriction shall apply
only to any current, former or prospective customer of the Company with whom you had contact with during the last twelve (12) months of
your employment with the Company.

 

		C.	Non-Solicitation of Employees.  You agree that during the Relevant Period, you will not directly
or indirectly knowingly solicit, recruit or hire any other employee of the Company with whom you had contact during your employment with
the Company other than any such employee whose employment with the Company terminated at least six months prior to such solicitation,
recruitment or hiring.

 

    7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]